Inactive Instrument

Press Releases Miromatrix Medical Inc.

Equities

MIRO

US60471P1084

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

MIROMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Miromatrix Medical Inc. - MIRO	Nov. 15	BU
Miromatrix Reports Third Quarter 2023 Results	Nov. 14	AQ
MIROMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Miromatrix Medical Inc. - MIRO	Nov. 01	BU
Shareholder Alert: Ademi LLP investigates whether Miromatrix Medical Inc. has obtained a Fair Price in its transaction with United Therapeutics	23-10-31	PR
MIRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Miromatrix Medical Inc. Is Fair to Shareholders	23-10-30	BU
Miromatrix to Present at the 2023 ISODP Organ Donation Congress	23-10-11	AQ
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa	23-10-05	AQ
Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference	23-09-06	AQ
Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop	23-09-05	AQ
Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update	23-08-14	AQ
Miromatrix to Report Second Quarter 2023 Financial Results	23-07-25	AQ
Miromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement Award	23-07-13	AQ
Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D	23-06-01	AQ
Miromatrix Presenting at the 2023 American Transplant Congress	23-05-30	AQ
Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference	23-05-30	AQ
Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update	23-05-11	AQ
Miromatrix to Report First Quarter 2023 Financial Results	23-04-27	AQ
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med	23-04-10	AQ
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation	23-04-05	AQ
MIROMATRIX MEDICAL INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-31	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Miromatrix Medical Inc.

Equities

MIRO

US60471P1084

Press Releases

Filters